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ABSTRACT
Background: Fructooligosaccharides (FOS) in prebiotic foods can alter intestinal immune responses. The
combination of probiotics with oligosaccharides has been reported to alter intestinal flora and suggested to be
beneficial against food allergy in humans.
Methods: All male Ncjic mice used in this 8-week study were 6 weeks of age and were allotted to the follow-
ing three groups: (1) the nonsensitization group; (2) the ovalbumin (OVA) sensitization +5% fructose-containing
control food administration group; and (3) the OVA sensitization +5% FOS-containing food administration
group. Duodenal tissues were collected and then immunohistochemically stained with monoclonal antibodies to
CCR4 and CCR5. The number of mast cells and the villus edema formation rate in the duodenum were deter-
mined by image analysis.
Results: The number of CCR4-positive cells increased significantly in Group 2 as compared with Group 1 and
tended to decrease in Group 3 as compared with Group 2. Relatively few CCR5-positive cells were observed in
the duodenum. FOS tended to reduce the number of CCR4-positive cells but significantly reduced the number
of mast cells and the edema formation rate in the duodenum.
Conclusions: This study demonstrated a correlation between the number of CCR4-positive cells and villus
edema formation rate. Therefore, FOS, which we inferred to show antiallergic activity for food allergy in this
study and which has already been established to be safe for use as food in humans, can be considered to be
potentially useful for the prevention of food allergy in pediatric patients with allergy.
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INTRODUCTION
The number of pediatric patients with food allergy
has increased in recent years. However, the standard
therapeutic modality for the disease is still not estab-
lished, and treatments, including food restriction, fail
to be sufficiently effective for the disease at present.1
Since a long period of time is required to treat the dis-
ease in children, food restriction elicits concern about
the issue of child growth. Therefore, the develop-
ment of new therapeutic modalities and preventive
procedures for food allergy constitutes a challenge in
clinical practice. In the United States, patients with
food allergies have been reported to account for 8%
and 1 to 2% of pediatric patients 3 years of age and
the total population, respectively.2 In Japan, patients
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Fig. 1 Composition of the study groups and administration schedule. The study groups 
comprised three groups. Group 1 (OVA nonsensitization group) consisted of 10 intact mice 
which were not sensitized with OVA and which were alowed to take control food for 8 
weeks. Group 2 (control group) consisted of six mice which were sensitized with OVA and 
were then alowed to take control food for 8 weeks. Group 3 (FOS administration group) 
consisted of seven mice which were sensitized with OVA and were then alowed to take 
5% FOS-containing food for 8 weeks. To sensitize mice, 100 μg of ovalbumin were given 
by oral gavage, along with five consecutive intraperitoneal administrations of a mixed solu-
tion (100 μg of OVA and 0.1 mL of adjuvant) every other week. Nonsensitized control mice 
were treated similarly except using the same volume of saline instead of the OVA solution. 
At the end of the study, OVA (2 mg/0.1 mL) was given by oral gavage to mice in order to 
conduct antigen chalenge.
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Sensitization
with immediate food allergy account for 12.6% of pedi-
atric patients with allergy less than 6 years of age,
and their number has tended to increase in recent
years.3 In 2005, the food allergy guidelines were im-
plemented also in Japan. Treatment of food allergy
consists principally in the removal or restriction of
food.
In recent years, the understanding of the relation-
ship between the intestinal flora and allergy has ad-
vanced rapidly. The disruption of intestinal barrier
function is considered one of the mechanisms by
which food allergy develops. Clinical studies have re-
ported that lactobacillus preparations improved the
incidence of atopic dermatitis and dermatological
symptoms4-8 and ameliorated food allergy.9 However,
prebiotic foods possess advantages in that they are
free of side effects and are administrable to children,
including younger children and pediatric patients
with milk allergy, for a long period of time. Probiotics
have been reported to improve small intestinal bar-
rier function. Therefore, we hypothesized that the ad-
ministration of fructooligosaccharides (FOS) alone al-
ters intestinal bacterial flora and repairs intestinal
barrier function, resulting in the improvement of
symptoms of food allergy.
We prepared a mouse model of food allergy in the
present study to examine the mechanism of action of
FOS, using the numbers of CCR4- and CCR5-positive
cells and the villus edema formation rate in the duo-
denum as variables for examining their potential
roles in the prevention and treatment of food allergy.
We used CCR5- and CCR4-positive cells in Th1 and
Th2 immune responses, respectively, because they
are considered to be present independently in Th1
and Th2 cells. Th2 cells (CCR4 positivity cells) in
blood have been reported to increase under allergy
environments.10-12
Here we report the results of an in vivo study.
METHODS
ANIMALS AND THE COMPOSITION OF STUDY
GROUPS
At the onset of the study, all male NCjic mice, 6
weeks of age and 24.2 ± 0.7 grams in body weight
(CLEA Japan, Tokyo, Japan), were housed under spe-
cial pathogen-free (SPF) environments.
Prior to the onset of this 8-week study, the animals
were allotted to the following three study groups:
Group 1 (n = 10) in which they were not sensitized
with ovalbumin (OVA) and were then allowed to
freely take control food (CE-2; CLEA Japan) contain-
ing 5% fructose; Group 2 (n = 6) in which they were
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sensitized with OVA and were then allowed to freely
take control food containing 5% fructose; and Group 3
(n = 7) in which they were sensitized with OVA and
were then allowed to freely take food containing 5%
FOS.
METHOD OF SENSITIZATION
A mouse model of food allergy was prepared accord-
ing to the method of Sakamoto et al..13 Briefly, a gas-
tric tube was used to give 100 μg of ovalbumin (OVA;
Sigma, St., Louise, MS, USA) by oral gavage, along
with 5 consecutive intraperitoneal administrations of
a mixed solution consisting of 100 μg of OVA and 0.1
mL of adjuvant (Imject Alum®; Pierce, Rockford, IL,
USA) every other week. OVA was dissolved in saline
before use. Nonsensitized control mice were treated
similarly except using the same volume of saline in-
stead of the OVA solution. At the end of the study,
OVA (2 mg0.1 mL) was given by oral gavage to mice
in order to conduct antigen challenge (Fig. 1). At 3
hours after antigen challenge, mice were sacrificed to
remove organs.
The present study was approved by the Animal Re-
search Ethics Committee at Showa University.
DETERMINATION OF SERUM TOTAL IgE ANTI-
BODY LEVELS AND SERUM OVA-SPECIFIC IgE
ANTIBODY LEVELS
A kit (IgE, Mouse, ELISA Quantitation Kit®; Bethyl
Laboratory, Montgomery, TX, USA) was used to de-
termine serum total IgE antibody levels.
Serum OVA-specific IgE antibody levels were de-
termined by ELISA according to the method of
Hirano et al..14 Namely, a microplate reader was used
to determine the level in optical density at 450 nm
(OD450).
We verified sensitization by serum total IgE anti-
body levels and serum OVA-specific IgE levels. The
mean +2 SD of serum total IgE antibody levels or se-
rum OVA-specific IgE levels in Group 1 (n = 10) was
used as the cutoff value.
Immunohistochemical Staining
Immunohistochemical staining (streptavidin-biotin
method) was conducted to examine the tissue distri-
butions of Th1- and Th2-positive cells. The following
antibodies were used as primary antibodies: anti-
mouse CCR4 rabbit IgG1 [Antiserum (purified) to
CCR4 (mouse)®, the 100-fold dilution of the concen-
trate solution; Alexis Biochemicals, San Diego, CA,
USA] to detect CCR4; and antimouse CCR5 goat
IgG1 [CKR-5 (M-20)®, the 100-fold dilution of the
concentrate solution; Santa Cruz Biotechnology,
Santa Cruz, CA, USA] to detect CCR5.
HISTOMOUSE-PULUS KITS®, manufactured by
ZYMED (streptavidin-biotin amplification), was used
according to the LAB-SA method. Sections blocked
with intrinsic peroxidase, avidin, and biotin, as well as
washed with the 0.01 M phospate buffer solution
were incubated with the first antibodies at room tem-
perature for 60 minutes. Subsequently, biotinylated
second antibody and labeling enzyme were incubated
for 30 and 20 minutes, respectively. A substrate
(DAB) was used for coloring operation over 3 min-
utes.
Counting of positive cells was performed in the fol-
lowing procedures: (1) selection of the observation
site from 3 sites; (2) observation of photomicrographs
of damage-free villi; (3) determination of a site where
negative control had neither nonspecific binding
(NSB) nor background; and (4) observation of round
nucleated cells 8 to 12 μm in diameter.
HISTOPATHOLOGICAL ANALYSIS OF THE DUO-
DENUM
A 15 mm long segment of the duodenum, located 50
mm from the pylorus of the stomach, was removed
and was then fixed in the 10% buffered formalin solu-
tion for 12 hours. H&E stain and toluidine blue (pH
7.4) stains were applied.
MicroGrid® was used to count mast cells in the
duodenum at 3 sites where tissue remained intact.
The mean of the counts was used to evaluate the
cells. All histological examinations were conducted in
a blinded fashion.
CALCULATION OF DUODENAL VILLUS EDEMA
FORMATION RATES
Graphic software (WinRoof, version 5・0; Mitani
Syoji, Tokyo, Japan) was used to calculate the edema
formation rate of the duodenal villi. To determine the
sites of calculation, 3 duodenal villi, which were free
of tissue damage and contained the layer of muscu-
laris mucosae, were selected from H&E-stained sam-
ples. All mice were coded and conducted in a blinded
fashion. The mean area thereof was used to evaluate
the rate. The total area per villus and the area occu-
pied by edema were calculated automatically, and the
ratio thereof was considered as the edema formation
rate per villus. In order to avoid making the coeffi-
cient of variation for repeated measurements the dif-
ference between operating personnel, calculations
were carried out by automatic analysis using WinRoof
(Fig. 2). The mean +2 SD of the edema formation rate
per villus in Group 1 (n = 10) was used as the cutoff
value.
STATISTICAL ANALYSES
Values were expressed as the mean ± SE. JMP ver-
sion 4.00 J (SAS Institute Inc., Cary, NC, USA) was
used to conduct statistical analyses. The Wilcoxon
rank-sum test and the Kruskal-Wallis rank test were
conducted for rank sum and comparisons among the
three study groups, respectively. The Spearman rank
correlation coefficient was used to make correlation
analyses. A value of P < 0.05 was considered statisti-
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Fig. 2 The image analysis procedure in the duodenum. 
The total area per vilus and the area occupied by edema 
were calculated, and the ratio thereof was considered the 
edema formation rate per vilus.
OVA nonsensitization group  OVA sensitization group
Fig. 3 Number (cel/mm2) of CCR4-positive cels in the 
duodenal vili of mice in the study groups. Group 2 (control 
group) showed a significant increase (P＜ 0.001) as com-
pared with Group 1 (OVA nonsensitization group) with re-
spect to the number (cel/mm2) of CCR4-positive cels. 
Group 3 (FOS administration group) tended to show a difer-
ence as compared with Group 2 (control group) which was 
determined in accordance with the criterion for CCR4-posi-
tive cel counting.
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RESULTS
SERUM TOTAL IgE LEVELS AND SERUM OVA-
SPECIFIC IgE LEVELS
The mean + 2 SD of serum OVA-specific IgE levels in
Group 1 (n = 10) was used as the cutoff value (OD
450 : 0.08). The cutoff value of serum total IgE was
4031.4 ngmL. Consequently, all animals in Groups 2
and 3 provided serum OVA-specific IgE levels which
exceeded the cutoff value. Therefore, the sensitiza-
tion rate was assessed to be 100%.
Serum total IgE levels (mean ± SE) were as fol-
lows: 1,131.2 ± 1499.7 ngmL (n = 10) in Group 1
(OVA nonsensitization group); 6,525.9 ± 1,936.1 ng
mL (n = 6) in Group 2 (Control group); and 14,449.9 ±
1,792.5 ngmL (n = 7) in Group 3 (FOS administra-
tion group). Furthermore, serum OVA-specific IgE
levels (mean ± SE) were as follows: 0.05 ± 0.05 OD
450 (n = 10) in Group 1; 0.44 ± 0.07 OD450 (n = 5) in
Group 2); and 0.67 ± 0.06 OD450 (n = 7) in Group 3.
Serum total IgE levels and serum OVA-specific IgE
levels increased significantly in Groups 2 and 3 (P <
0.05 and P < 0.001, respectively) as compared with
Group 1. There was a significant correlation (r = 0.78,
p < 0.0001) between serum OVA-specific IgE levels
and serum total IgE levels.
NUMBERS OF CCR4- AND CCR5-POSITIVE
CELLS
The numbers of CCR4-positive cells (cellmm2;
mean ± SE) were as follows: 30.5 ± 16.9 (n = 10) in
Group 1; 145.2 ± 21.9 (n = 6) in Group 2; and 87.1 ±
20.2 (n = 7) in Group 3 (Fig. 3). The numbers thus in-
creased significantly (P < 0.001) in Group 2 as com-
pared with Group 1. On the other hand, Group 3
showed no statistically significant difference in the
numbers as compared with Group 2 but showed a de-
crease in the number of CCR4-positive cells. A large
number of CCR4-positive cells were observed in the
mucous layer of the duodenal villi. Apart from lym-
phocytes, which are considered to be monocytes,
dendritic cells were also observed among CCR4-
positive cells.
CCR5-positive cells (cellmm2) in the duodenal villi
were observed only in one of 10 mice in Group 1
(CCR5CCR4 = 0.15). Furthermore, a small number
of CCR5-positive cells were observed in the submu-
cosa (Fig. 4). No significant difference was found
among Groups with respect to the number of CCR5-
positive cells. On the other hand, a significant correla-
tion (r = 0.61, p = 0.0027) between serum OVA-
specific IgE level and the number of CCR4-positive
cells was observed. Furthermore, a significant corre-
lation (r = 0.49, p = 0.017) was found among serum to-
tal IgE level and number of CCR4-positive cells.
NUMBER OF MAST CELLS IN THE DUODENUM
The numbers (cellmm2) of mast cells in the duode-
num of mice in Groups 1, 2, and 3 are shown in Fig-
ure 5. The numbers (mean ± SE) were as follows:
86.6 ± 6.7 (n = 10) in Group 1; 163.4 ± 8.7 (n = 6) in
Group 2; and 58.4 ± 8.0 (n = 7) in Group 3. Mast cells
in the duodenum were observed in the perivascular
region underneath the muscularis mucosae. The
number of mast cells increased significantly (P <
0.05) in Group 2 as compared with Group 1. On the
Antiallergic Activity of Oligosaccharides
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Fig. 4 Immunohistochemical photomicrographs of CCR4- and CCR5-positive cels. A 15 mm 
long section of the duodenum, located at 50 mm from the pylorus of the stomach, was removed 
and used to conduct immunohistological staining. Immunohistochemical photomicrographs of 
CCR4-positive cels (brown; arow) (Panel A) and CCR5-positive cels (Panel B) in the duodenal 
vili. A number of CCR4-positive cels were observed in the mucus layer of the duodenal vili. A 
smal number of CCR5-positive cels were observed in the lymphatic tissue (Panel C) (immunohis-
tochemical staining, ×400).
other hand, the number of mast cells decreased sig-
nificantly (P < 0.001) in Group 3 against Group 2. The
number of mast cells and the number of CCR4-
positive cells increased significantly (P < 0.05 and P <
0.001, respectively) in Group 2 as compared with
Group 1. In Group 3, however, the number of mast
cells decreased significantly (P < 0.001); no correla-
tion (r = 0.20, p = 0.36) was found between the num-
ber of CCR4-positive cells and the number of mast
cells.
HISTOPATHOLOGY
Regarding the abnormal value detection ratio, one
(110) mouse in Group 1 showed edematous changes
in the duodenal villi. On the other hand, 100% (66) of
the mice in Group 2 showed severe edematous
changes in their duodenal villi. However, 29% (27) of
the animals in Group 3 showed a persistence of ede-
matous changes and histochemical photomicro-
graphs demonstrated duodenal villi which repaired to
an extent close to those of animals in Group 1. In
Group 2, the edematous changes occurred in mu-
cosal tissue of the duodenal villi with inflammatory
cell infiltration around the vessels.
DETERMINATION OF DUODENAL VILLUS
EDEMA FORMATION RATES
The duodenal villus edema formation rates in Groups
are shown in Figure 6. The edema formation rates
per villus (mean ± SE) were as follows: 0.95 ± 0.53%
(n = 10) in Group 1; 6.86 ± 0.69% (n = 6) in Group 2;
and 1.93 ± 0.64% (n = 7) in Group 3 (mean ± SE). The
cutoff value of the edema formation rate per villus in
Group 1 was 1.99％one villus. The rates increased
significantly (P < 0.001) in Group 2 as compared with
Group 1. The rates decreased significantly (P < 0.05)
in Group 3 as compared with Group 2. A correlation
(r = 0.70, p = 0.0002) was found between the number
of CCR4-positive cells and the duodenal villus edema
formation rate (Fig. 7). A correlation (r = 0.48, p =
0.02) was found between the number of mast cells
and the duodenal villus edema formation rate (Fig.
Fujitani S et al.
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Fig. 5 Numbers of mast cels in duodenal vili of mice in 
the study groups. A number of toluidine blue-stained mast 
cels in the duodenum were observed in the perivascular 
area underneath the muscularis mucosae. Group 2 (control 
group) showed a significant increase (P＜0.05) in the num-
ber of mast cels as compared with Group 1 (OVA nonsensi-
tization group). Group 3 (FOS administration group) showed 
a significant decrease (P＜ 0.001) in the number of mast 
cels as compared with Group 2 (control group).
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Fig. 6 Edema formation rates in the duodenal vili in the 
study groups. The edema formation rates per vilus (mean ± 
SE) were as folows: 0.95 ± 0.53% (n＝ 10) in Group 1; 
6.86 ± 0.69% (n＝6) in Group 2; and 1.93 ± 0.64% (n＝7) 
in Group 3 (mean ± SE). The rates increased significantly 
(P＜ 0.001) in Group 2 as compared with Group 1. The 
rates decrease significantly (P＜ 0.05) in Group 3 as com
pared with Group 2.
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Fig. 7 Corelations between the number of CCR4-positive 
cels and the duodenal vilus edema formation rate. A signifi-
cant corelation (r＝0.70, p＝0.0002) was noted between 
the number of CCR4-positive cels and the edema formation 
rate. Group 2 (control group) showed significant increases 
(P＜0.001) in the edema formation rate and in the number 
of CCR4-positive cels as compared with Group 1 (OVA non-
sensitization group). Group 3 (FOS administration group) 
showed significant decreases (P＜0.05) in the vilus edema 
formation rate as compared with Group 2. However, Group 
3 tended to show a decrease in the number of CCR4-posi-
tive cels as compared with Group 1.
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Fig. 8 Corelations between the number of mast cels and 
the duodenal vilus edema formation rate. A significant core
lation (r＝0.48, p＝0.02) was noted between the number of 
mast cels and the edema formation rate. Group 2 (control 
group) showed significant increases (P＜ 0.001, P＜ 0.05) 
in the edema formation rate and in the number of mast cels 
as compared with Group 1 (OVA nonsensitization group).
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DISCUSSION
The gastrointestinal tract of humans is constantly ex-
posed to uncountable numbers of environmental mi-
croorganisms, food proteins, and other substances.
Defense against these potential threats occurs
through specific barrier mechanisms while maintain-
ing interactions with the intestinal flora. When the
mechanisms are disrupted due to repeated stimula-
Antiallergic Activity of Oligosaccharides
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tion by antigens and from other events, orally incor-
porated food antigens are able to pass across the
mechanisms, activate T cells via antigen-presenting
cells, e.g., dendric cells, macrophages and B cells,
and induce a Th1- or Th2-type immune response.
Subsequently, activated lymphocytes are considered
to migrate to the intestinal mucosa via mesenteric
lymph nodes, where allergic symptoms develop.
We focused our attention on the Th2 cells in the
duodenum in an attempt to examine their relation-
ship with the mechanisms of the pathogenesis of al-
lergy after challenge with the OVA antigen, as well as
the effects of FOS on these cells. Regarding the inter-
cellular specificity of the variables, the expression of
CCR4 has been previously reported.15-17 Therefore,
the possibility that cells other than helper T cells
were overcounted was admissible. We hence endeav-
ored to make precise evaluations by establishing as-
sessment criteria which were based on the typical
morphological features of lymphocytes.
In our study we found that relatively few CCR5-
positive cells were expressed in the duodenal villi,
and expressed cells were mostly represented by
CCR4-positive cells (Fig. 4). Similarly to a previous
study on peripheral blood by flow cytometry,10-12 our
results demonstrated a predominance of Th2-positive
cells in the small intestine. In consideration of the fact
that the number of CCR4-positive cells increased sig-
nificantly after challenge with the OVA antigen, find-
ings from the present study furthermore indicated
that the small intestine, similar to the skin, consti-
tutes a target organ for T cells and that the small in-
testine provides an environment where Th2-positive
cells predominate.
In the present study, the significant correlation of
the number of CCR4 positive cells and the rate of
duodenal villus edema suggests that the cellular type
(delayed type) allergic reaction may have occurred.
Furthermore, in Group 2, the increase in both OVA-
specific IgE levels and the number of mast cells indi-
cated that the IgE-dependent allergy reaction may
have occurred. Tissue damage of the duodenum was
represented only by edema and inflammatory cell in-
filtration, all of which were reversible lesions. The de-
velopment of duodenal villus edema was considered
attributable to the actions of substances which were
released by mast cells and Th2-positive cells, e.g.,
chemical mediators and cytokines.
In consideration of the major findings, namely that
the number of CCR4 positive cells increased, and the
duodenal villi showed edematous changes, we can as-
sume that the following events occurred: 1) Antigens,
which succeeded in passing across defense barrier
mechanisms that were debilitated by villus edema
and penetrated the submucosal tissue of the small in-
testine; 2) Particular APCs, including M cells and DC
cells, presented antigens to T cells at selected sites,
such as Peyer patches where T cells were sensitized
to antigens; 3) The number of memory T cells in-
creased to recirculate in tissues where lymphocytes
were present, including the lamina propria mucosae
of the gastrointestinal tract; 4) T cells, which had
been in an unactivated condition (resting state), in
which the threshold for antigen response was lower
than that of other T cells, were also activated as a sur-
veillant by stimulation with antigens in the lamina
propria mucosae; and 5) Activated T cells infiltrated
tissues where allergic inflammation occurred, thus
leading to an increase in the number of measured
cells. Therefore, duodenal villi showed edematous
changes. On the other hand, in the case that the anti-
gen which penetrated is a microorganism, a Th1-type
immune response is elicited by the activation of toll-
like receptors.18 Therefore, we consider that Th1-
positive cells were not induced in the present study.
As the 2005 Japanese guidelines state,1 current
therapeutic modalities present limitations; namely,
the actual condition depicts a lack of effective meas-
ures. The present study revealed that tissue damage
does not progress if the intestinal barrier mechanism
repairs or improves successfully in clinical settings.
In Japan, FOS, health foods with intestine-
controlling activity whose function is allowed to be
displayed commercially, have extensively been con-
sumed by the Japanese population, ranging from in-
fants to the elderly. No side effects have been re-
ported from them over the last 12 years.
The pharmacological actions of FOS reported to
date are as follows: colitis-alleviating activity of TNBS
in rats by Christine C et al.19; colon cancer incidence-
lowering activity of FOS in mice by Fabrile Pierre et
al.20; increasing activity of FOS on the secretion of
IgA from intestinal Peyer patches and their Th2 cell-
inhibitory activity21; and increasing activity of FOS on
the secretion of IgA from the intestines of infant
mice.22
All studies have demonstrated the immunoregula-
tory activity of FOS in the intestines and reported that
FOS may sustain and improve the barrier mecha-
nisms of the intestines by controlling the intestinal
flora and intestinal organic acid concentrations. FOS
administration changes the intestinal environment of
microflora by increasing anaerobic bacteria, such as
Bifidobacterium and Lactobacillus and leads to
upregulation of IgA secretion of the systemic immune
response.21 In addition, IgA adsorbs to macromole-
cule protein as allergen and prevents absorption in
the small intestine. Furthermore, FOS increases
short-chain fatty acid concentration, and decreases
pH in the intestines. This environment does not pro-
mote proliferation of some pathogenic microbes, and
improves barrier mechanisms of the intestines. In
this way, the present study similarly showed vari-
ations in the intestinal flora and intestinal organic
acid concentrations due to the administration of FOS
(data not shown) and involves potential unreproduci-
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bility because of the use of special experimental ani-
mals.
As compared with Group 1, Group 2 showed sig-
nificant increases in all variables examined, i.e., num-
ber of CCR4-positive cells, villus edema formation
rate, number of mast cells, and serum OVA-specific
IgE levels. These findings indicated that the in-
creases in the numbers of CCR4-positive cells and
mast cells contribute to the allergic reaction in the
duodenum and that villus edema is provoked by aller-
gic reaction in the duodenum. In other words, these
findings suggest that the control of the allergic reac-
tion in the duodenum is essential for improving food
allergy. Furthermore, the fact that FOS tended to re-
duce the number of CCR4-positive cells indicates that
its allergenicity is not potent. However, the fact that
there was a significant decrease in the number of
mast cells suggests the possibility of the antiallergic
activity of FOS.
In conclusion, this study demonstrated a correla-
tion between the number of CCR4-positive cells and
villus edema formation rate. Therefore, FOS, whose
antiallergic activity for food allergy was inferred in
this study and whose safety as food in humans has al-
ready been established, can be considered to be po-
tentially useful for the prevention of food allergy in
pediatric patients, especially those with a milk al-
lergy.
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